Author Guidelines

Thank you for contributing to Personalized Medicine in Oncology (PMO)! We are looking forward to working with you. Once your submission is complete, please e-mail it along with a high resolution photograph of the author(s) to editorial@the-lynx-group.com. Manuscript Please use AMA style. Content should be medically accurate and reflect fair balance. Manuscripts will be reviewed for accuracy and balance, then edited for sense, style, and layout. Manuscripts should be saved as a Microsoft Word document, version 6.0 or higher. Cover page should contain title and authors, including complete degree/title/affiliation and contact information for each author. Drug names should be complete and generic –brand names may be used in first mention only but may be edited out according to the journal style. Dosages should be included. Abbreviations/acronyms should be spelled out at first mention. Word Count (not including references, tables/figures) As a suggestion, articles should be no longer than 3500 words of text, plus 2-3 figures/tables. Cite all tables/figures in text. Provide brief captions. In some cases, a longer submission may be acceptable. References References should be cited in text and numbered in the order cited. Use AMA style. Try not to exceed 35 references per article. Recent references are preferred. Please do not insert automatic footnotes or end notes. Figures (charts, graphs,pictures, etc) Cite in text. Provide as separate documents, using jpeg or eps format. Please provide succinct captions and legends containing source (if any). Please spell out acronyms. Tables Cite in text. Provide as separate documents, in a Word Table format. Please provide a succinct title for each table. Photographs Black and white or color photographs, professional quality. If electronic file, no less than 300 dpi. Submission Complete manuscripts (containing title, authors, figures, tables, references) should be submitted via email toeditorial@the-lynx-group.com. Per journal policy, authors will be required to complete and sign copyright release forms and financial disclosure statements (if CE accredited). Any questions regarding these guidelines should be addressed to the Editorial Director. Permissions Copyright of the article, including the right to reproduce the article in all forms and media, shall be assigned exclusively to Green Hill Healthcare Communications, LLC, an affiliate of the Lynx Group. Green Hill Healthcare Communications will not refuse any reasonable request by the author for permission to reproduce any of his or her contributions to Green Hill Healthcare Communications. If any portion of an article submitted for consideration, including figures or tables, has been previously published, please obtain permission from the copyright holder. Permission is required regardless of authorship or publisher, except for documents in the public domain. Contact Information Editorial Director:KristinSiyahian, 11896SweetbriarLane, San Diego, CA 92131. Phone: 858-382-4180; Fax: 858-549-9007; e-mail: editorial@the-lynx-group.com. Mission Statement The mission ofPersonalized Medicine in Oncology is to deliver practice-changing information to clinicians about customizing healthcare based on molecular profiling technologies, each patient’s unique genetic blueprint, and their specific, individual psychosocial profile, preferences, and circumstances relevant to the process of care. General Information PMO welcomes articles on topics relevant to our mission. The editors invite authors to submit original research, review articles, survey results, case studies, and white papers, as well as brief analyses of industry trends, perspectives, and letters relevant to published articles. Manuscripts submitted must be original and must not have been published previously, either in print or in electronic form. Manuscripts cannot be submitted elsewhere while under consideration by PMO. All authors must sign an appropriate disclosure form and a copyright transfer/authorship form. Peer Review/Editing All articles undergo an initial internal review for topic appropriateness and manuscript format. Manuscripts that are not submitted according to the guidelines in this document will be returned to the author. All manuscripts are subject to a peer review, and acceptance is based entirely on that review. Reviewers look for the accuracy of the information and data presented, as well as the relevance to the objectives of PMO. Routine editorial changes are made on all articles to conform to house style, following the AMA Manual of Style, 10th ed.1 The edited manuscript is sent to the corresponding author for a final review and for any outstanding editorial queries. Time from submission to publication is generally 4 to 7 months, but could be longer, depending on the peer-review and editing processes. Authorship/Copyright Authors listed on the manuscript should only include those who have made a direct contribution to the content of the article, in accordance with the authorship criteria provided by the International Committee of Medical Journal Editors (ICMJE).2 Credit for authorship is based on a substantial contribution to: (1) conception and design, or data analysis/interpretation; (2) drafting or revising the article critically for intellectual content; and (3) approval of the final version to be published. These 3 criteria must all be met.2 Those who have contributed to the article but do not meet these authorship criteria should be acknowledged at the end of the article. Provide authors’ highest academic degree and professional affiliations. Also provide the name, address, telephone number, e-mail, and fax number of the corresponding author. The corresponding author is responsible for securing signatures for all forms from all authors. All authors are required to sign an Authorship/Copyright Transfer Form, assigning all copyrights for the manuscript to Greenhill Healthcare Communications, LLC, publisher of PMO. For an article to be considered for publication, authors must adhere to the manuscript format described in this document and follow the general ICMJE guidelines.2 Disclosure Statements All authors must disclose any relationship that could be viewed as a potential conflict of interest, based on ICMJE guidelines,2 including any financial interests, direct or indirect, and any affiliations or involvement (competitive or amiable) with organizations that have a financial interest in the subject matter or materials discussed in the manuscript. Each author must sign the Financial Disclosure Form in accordance with the ICMJE guidelines.2 PMOdiscloses all information regarding employment, consultancies, stock ownership, honoraria, grants, or other financial sources with potential conflict of interest in relation to a manuscript, or if authors discuss any products or services with such commercial interest. Any information regarding funding, grants, or other financial compensation must be listed on the title page of the manuscript. All published articles will include disclosure statements listing any relationships with real or potential conflict of interest for all authors and for the manuscript/research.

  1. AMA Manual of Style. A Guide for Authors and Editors. 10th ed. New York, NY: Oxford University Press; 2007.
  2. nternational Committee of Medical Journal Editors. Uniform Requirements for Manuscripts Submitted to Biomedical Journals: Writing and Editing for Biomedical Publication. Updated April 2010.www.icmje.org/urm_full.pdf. Accessed August 23, 2012.